- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India

Biologics Market

Schedule a Call

Biologics Market (2022 to 2032)

The global biologics market was valued at around US$ 335.43 Billion at the end of 2021. The market is projected to register an 8.5% CAGR and top a valuation of US$ 817.48 Billion by 2032.

Rising incidence of chronic diseases and their diagnoses, increasing government initiatives, and increased availability of advanced diagnostics are expected to uplift the biologics market growth.

Biologic drugs are produced by genetic engineering and are composed of proteins taken from human genes. Biologic medications are made up of items like blood and blood components, gene therapy, somatic cells, vaccines, allergens, tissues, and recombinant therapeutic proteins and are obtained from several natural sources, including animals, humans, or microorganisms. Disease-modifying antirheumatic medicines (DMARDs) that contain living organism components or are made from living organisms are known as biologics or biological drugs. Biologics are produced using complex methods and Advanced biotechnology techniques.



Biologics Market Value in 2021

US$ 335.4 Billion

Biologics Market Value in 2032

US$ 817.4 Billion

Biologics Market CAGR (2022 to 2032)


Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers Boosting the Demand for Biologics Market?

A significant element influencing the biologics market's growth rate throughout the forecast period is the rising prevalence of chronic diseases. Oral product efficacy for Crohn's and rheumatoid arthritis attract more moderate patients to the biologics drug and new treatments. The market for biologics is being driven by factors such as big brand-name drugs losing their patent rights, an increase in the prevalence of chronic diseases and the diagnosis of those diseases, and an increase in the technological advancements in research and development by major key players of the pharmaceutical industry. Additionally, researchers are looking toward species and expression systems that have the potential to be more productive. Revenue growth is expected to be fuelled by the development of cell lines and reagents that increase the productivity of biological products.

Which Region Shows Strong Growth Potential in the Biologics Market?

The established economy of North America is anticipated to drive demand for biologics, followed by Europe and Asian regions. The overall sales of biologics in North America are anticipated to increase as the systematic drug review process and increasing technological advancement in the healthcare industry.

Furthermore, greater patient awareness, innovative strategies developed by key players, and regulatory harmonization regions are expected to experience rapid growth in the biologics control market in the European regions.

Moreover, the Middle East and Africa regions are likely to experience sustainable growth in the forecast period due to rising disease incidences in these countries.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Players in the Biologics Market?

Some of the market players operating in the biologics market are Novartis AG, Pfizer Inc, Dickinson & Company, Smiths Medicals, Roche Diagnostics, AstraZeneca, Bayer AG, GSK Biologicals, Samsung BioLogics, Merck & Co., Inc., Eli Lilly, and Company, Hoffmann-La Roche Ltd and AstraZeneca.

Scope of Report

Report Attributes


Growth Rate

CAGR of 8.5% from 2022 to 2032

Base Year for Estimation


Historical Data

2012 to 2021

Forecast Period

2022 to 2032

Qualitative Units

Revenue in USD Billion, and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segment Covered

  • Product
  • Application
  • Drug Classification
  • Mode of Purchase
  • Distribution Channel
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Israel

Key Players

  • Novartis AG
  • Pfizer Inc
  • Dickinson & Company
  • Smith’s Medicals
  • Roche Diagnostics
  • AstraZeneca
  • Bayer AG
  • GSK Biologicals
  • Samsung BioLogics
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd
  • AstraZeneca.


Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Biologics Industry Survey

By Product:

  • Monoclonal Antibodies
  • Recombinant Hormones/Proteins
  • Vaccines
  • Cellular Based Biologics
  • Gene-Based Biologics
  • Therapeutic Enzymes
  • Others

By Application:

  • Infectious Diseases
  • Cancer
  • Autoimmune Diseases
  • Rare Diseases
  • Others

By Drug Classification:

  • Branded Drugs
  • Generic Drugs

By Mode of Purchase:

  • Prescription Drugs
  • Over-The-Counter (OTC) Drugs

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The global biologics market is anticipated to register a CAGR of 8.5% during the forecast period.

The top players in the global biologics market are Novartis AG, Pfizer Inc, Dickinson & Company, Smiths Medicals, Roche Diagnostics, AstraZeneca, Bayer AG, GSK Biologicals, Samsung BioLogics, Merck & Co., Inc., Eli Lilly, and Company, Hoffmann-La Roche Ltd and AstraZeneca.

- Request for Table of Contents -

Complete the form below and we'll get back to you shortly

Your personal details are safe with us. Privacy Policy*

Explore Healthcare Insights

View Reports